Zealand Pharma A/S
ZLDPF
$62.50
-$0.79-1.25%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 98.92% | -86.79% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 98.92% | -86.79% | |||
| Cost of Revenue | 105.98% | -171.25% | |||
| Gross Profit | -24.00% | -54.27% | |||
| SG&A Expenses | 59.21% | 18.57% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -196.97% | -- | |||
| Total Operating Expenses | 11.06% | 19.73% | |||
| Operating Income | -9.95% | -33.31% | |||
| Income Before Tax | -5.62% | 7.01% | |||
| Income Tax Expenses | 59.53% | -6.69% | |||
| Earnings from Continuing Operations | -5.95% | 7.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.95% | 7.07% | |||
| EBIT | -9.95% | -33.31% | |||
| EBITDA | -11.19% | -34.34% | |||
| EPS Basic | -5.85% | 17.56% | |||
| Normalized Basic EPS | -0.90% | 13.08% | |||
| EPS Diluted | -5.85% | 17.56% | |||
| Normalized Diluted EPS | -0.90% | 13.08% | |||
| Average Basic Shares Outstanding | 0.11% | 12.72% | |||
| Average Diluted Shares Outstanding | 0.11% | 12.72% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
